.Pharmacolibrary.Drugs.ATC.A.A05AX06 .Pharmacolibrary.Drugs.ATC.A.A05AX06| name: | Elafibranor |
| ATC code: | A05AX06 | route: | oral |
| n-compartments | 2 |
Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR) alpha/delta agonist developed for the treatment of metabolic diseases, chiefly nonalcoholic steatohepatitis (NASH). It has been investigated in clinical trials but is not approved for clinical use as of 2024.
Pharmacokinetic parameters reported in healthy adult subjects after oral administration.